NUROCHEK

Introducing Nurochek, an FDA-cleared medical device that provides an objective concussion assessment in just 2 minutes.

Designed to standardise evaluations across healthcare facilities for the aid in diagnosis of concussion (mild traumatic brain injury or mTBI).

0

Years of development

0

International patents

0

Clinical trials in US, Australia and New Zealand

0

thousand data points per test

Innovative concussion assessment with AI proprietary technology, all in a single headset.

Tailored design – there is no current off-the-shelf solution

Fast results in just 2 minutes

Complex analysis of over 400,000 data points per test

Proprietary AI technology

10,000 EEG features distilled to 26

14 applicable CPT charge codes

Multiple FDA clearances

Winner of two Good Design awards

Secure cloud data storage

The Nurochek headset is designed to capture the electrical responses of the brain to visual stimuli. Our sophisticated AI model meticulously classifies these responses on a secure cloud server before transmitting the results to Windows computer.

Leading the race in concussion assessment

Nurochek Market Leader
Type EEG with AI Neurocognitive Test
Single Test 2 minutes 20 minutes
Approach Headset & PC App Desktop / laptop / tablet / corded mouse
Ease of use High Low
Objective Yes No
Baseline-free Yes No
Cost $ $
FDA-cleared for concussion

The Nurochek System is intended for prescription use in healthcare facilities for subjects aged between 16 and 46 years old, for the aid in diagnosis of mild traumatic brain injury (mTBI) in conjunction with a standard neurological assessment (FDA-cleared on 27 December 2023).

From formal incorporation in 2017, significant progress has been made.

2017

Feb 2017

HeadsafeIP Incorporated

Apr 2017

Clinical Advisory Panel appointed

May 2017

Slingshot HCF Catalyst Accelerator program

Jul 2017

Global Bridging Grant, Jobs4NSW MVP Grant

Aug 2017

Board constituted

2018

Jan 2018

ISO13485 prototype

April 2018

Jobs4NSW Building Partnerships Grant

May 2018

Research prototype

Nov 2018

$175,000 in Australian Government funding

2019

Feb 2019

Accepted to TMCx (Texas Medical Center Accelerator)

Mar 2019

Initial FDA Clearance

2021

Dec 2021

Second FDA submission

2023

Dec 2023

FDA clearance as Aid to Diagnosis

FAQs

What is Nurochek?

Nurochek is a new FDA cleared medical device for assessing brain function and as an aid to the diagnosis of concussion.

What is the Nurochek Headset?

The device is a headset which goes over the eyes and the back of the head like a set of VR goggles or a ski/diving mask. An adjustable strap makes it comfortable for the two-minute test.

How does Nurochek work

Nurochek stimulates the eyes with a 30 second flashing light sequence and the specialised senses on the back of the headset pick up the brains resulting electrical activity (an EEG or electroencephalograph). This process is called Visual Evoked Potentials (VEP) and the resulting data is analysed by sophisticated artificial intelligence (AI) program cleared by the FDA as an aid to diagnosis by a treating doctor.

Does Nurochek hurt?

Not in the slightest!

How long does a Nurochek test take?

The entire test takes around 2 minutes.

Are there any people who are not suitable for Nurochek?

Your check is not suitable at the present time for anyone with a history of seizure disorder, epilepsy or previous structural brain injury.

How is Nurochek data analysed?

Results are analysed through a sophisticated machine learning (ML) Artificial Intelligence (AI) algorithm and are graphically displayed on a PC App from a secure, online server.

Do I need to have a baseline reading at the beginning of the season?

Because of the ai process, a previous reading (or Baseline) is not required. Assessments can be made after an injury (in sports, a fall, motor vehicle accident etc) even if never assessed previously with Nurochek.

What is the research behind Nurochek?

Research in the US, Australia and New Zealand is ongoing to assess the utility of Nurochek as a point-of-care diagnostic aid for doctors in sports, EMS and hospital applications.

What regulatory approvals does Nurochek have?

Nurochek has two FDA clearances (USA) where it is recognised as an aid to the diagnosis of concussion in the hands of a licensed healthcare professional did neurological assessment. At present, the device is approved for ethically overseen research in Australia and regulatory approval from the TGA is anticipated for later this year. Approvals in New Zealand and South Africa are also pending.

Who can test me using Nurochek?

Nurochek is a prescription product for use by licensed healthcare professionals, and in research by qualified and appropriately trained personnel.

What is the science behind Nurochek?

Lots of work has been published on VEPs and on other Event Related Potentials (ERPs) which are electrical information from neural systems such as motor system (evoked through TMS Transcranial Magnetic Stimulation), the Visual-Ocular pathways, Acoustic pathways etc. These ERPs are all affected in concussion, because of the fact that individual nerves going to these different “systems” are all the same. Nurochek measures this electrical activity and determines if it is normal or abnormal.

Who decides when i can return to playing sport, or to go back to school or work?

Your doctor always makes these decisions about your health: Nurochek is designed as an aide to help the diagnosis.

Saving brains creates lasting value.

Discover how we’re leading the charge in concussion assessment.

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.